Little benefit seen when corticosteroids added to injections for spinal stenosis

July 2, 2014
Dr. Janna Friedly, an assistant professor of rehabilitation medicine at the University of Washington in Seattle, examines a patient's leg and foot in her clinic. Credit: Clare McLean

Epidural injections with a glucocorticoid in combination with the local anesthetic lidocaine appear to be no better in reducing pain and physical limitations in patients with spinal stenosis, a common spine disorder, than injections of lidocaine alone, a new study has found.

Glucocorticoids, also known as corticosteroids, are commonly used to treat inflammation.

"Compared to injections with local anesthetic alone, injections with glucocorticoids provided these with minimal or no additional benefit." said lead author Dr. Janna L. Friedly, an assistant professor of rehabilitation medicine at the University of Washington.

The study, which appears in the July 3 issue of the New England Journal of Medicine, is the largest, double-blind, to look at the purported effectiveness of this commonly administered treatment. An editorial in the same issue comments on the research.

In the study, 400 patients with back and caused by lumbar , a common cause of such pain in older adults, were randomly assigned to receive epidural injections containing either the local anesthetic alone or the anesthetic plus a glucocorticoids.

Lumbar spinal stenosis is often caused by age-related changes in the spine. The spinal canal narrows and compresses the nerves that run from the spinal cord to the back and legs. The compression can cause back and leg pain, as well as numbness, tingling, and weakness in the legs.

The condition is often treated with injections of local anesthetics plus corticosteroids into the epidural, or outermost, space of the . It is estimated that over 2.2 million lumbar epidural injections are performed each year in the Medicare population.

The benefit of these injections has been believed to be due to the effects of the corticosteroids. Proponents of the treatment hypothesize that the glucocorticoids relieve pain by reducing swelling and inflammation around the compressed spinal nerves. However, the efficacy of the treatment has been in doubt because it has never before been evaluated in a large, multi-center, double-blind, randomized trial.

The primary goal of the new study, called the Lumbar Epidural steroid injections for Spinal Stenosis (LESS) trial, was to determine whether there were any differences in pain or physical limitations six weeks after the injections between patients who received only versus patients who also received glucocorticoid. The researchers also looked several secondary outcomes including differences at three weeks, patient satisfaction, and depression.

The extent of pain and physical disability were assessed by asking patients to rate the intensity of their pain on a 0-10 scale and to complete a questionnaire that assesses caused by back or leg pain, called the Roland-Morris Disability Questionnaire (RMDQ). Patients completed these measures before the injections and again at three and six weeks after receiving the injections.

The study was conducted at 16 medical centers across the United States. Neither the patients nor their doctors knew whether the injections contained the combination of glucocorticoid and lidocaine or lidocaine alone. The study was funded by the U.S. Agency for Healthcare Research and Quality.

The researchers found that symptoms improved in both groups. At three weeks, those who received glucocorticoid reported slightly less leg pain and slightly better function, but by six weeks there were no significant differences between the two groups in either pain or function.

Patients who received glucocorticoid reported greater satisfaction with treatment, with 67 percent of those who received glucocorticoid reporting being "very" or "somewhat" satisfied compared to 54 percent of those who received lidocaine alone. They also improved more in depressive symptoms.

The researchers speculate that the increased sense of satisfaction reported by these patients may have been due to small early benefit seen with corticosteroid injections at three weeks. Glucocorticoids are also known to improve mood and reduce the sense of fatigue. These effects may also have contributed to their feeling of satisfaction, the researchers said.

However, patients who received corticosteroids also reported more adverse events and were more likely to have low morning serum cortisol levels three and six weeks after the injections. This suggests that the corticosteroid was being absorbed in the general circulation and may have had broad systemic effects, the researchers note. Systemic effects of corticosteroids include reduced bone mineral density, increased risk of bone fractures, and immunosuppression.

The findings call into question the routine use of epidural injections for spinal stenosis, Friedly said. "If patients are considering an epidural , they should talk to their doctor about a lidocaine-only injection, given that corticosteroids do pose risks and this study found that they provided no significant added benefit at six weeks."

Additional studies are needed to ascertain whether the lidocaine-only injections are of any true benefit, Friedly added. "It's unclear how a short-acting anesthetic like lidocaine could have a sustained effect on pain and mobility," she said.

Explore further: Steroid injection may lead to worse outcomes in patients with spinal stenosis

Related Stories

Steroid injection may lead to worse outcomes in patients with spinal stenosis

February 19, 2013
For patients with spinal stenosis, epidural steroid injections (ESI) may actually lead to worse outcomes—whether or not the patient later undergoes surgery, according to a study in the February 15 issue of Spine.

Need steroids? Maybe not for lower back pain: Analysis suggests saline shots may do just as well

September 17, 2013
New research from Johns Hopkins suggests that it may not be the steroids in spinal shots that provide relief from lower back pain, but the mere introduction of any of a number of fluids, such as anesthetics and saline, to ...

Etanercept cuts sciatic pain from lumbar disc herniation

November 1, 2013
(HealthDay)—Compared with placebo, transforaminal injections of etanercept provide relief from leg and back pain in patients with symptomatic lumbar disc herniation (LDH), according to research published in the Nov. 1 issue ...

Steroid injection linked with significant bone loss in postmenopausal women treated for back pain

December 1, 2012
Postmenopausal women suffered significant bone density loss in their hip after they were treated with an epidural steroid injection for back pain relief, according to a Henry Ford Hospital study

Vascular complications of fungal meningitis after contaminated spinal injections

July 22, 2013
A case series by researchers at Vanderbilt University, Nashville, Tenn., examined three patients with ischemic stroke who later received a diagnosis of fungal meningitis attributed to epidural injections of contaminated methylprednisolone ...

Steroid shots for sciatica: Benefits only brief, analysis finds

November 13, 2012
(HealthDay)—Spinal steroid injections—the type involved in the current fungal meningitis outbreak in the United States—provide only short-term relief for sciatica-related leg and back pain, according to a new analysis.

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.